Francis Richard D (CIK 1673277) reported 14 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-08). Recent activity: Buy TEVA (13,043 shares), Sell TEVA (6,153 shares), Buy TEVA (42,452 shares), Sell TEVA (20,025 shares), Buy TEVA (50,223 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-08 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | President and CEO | Buy | 13,043 | $0 |
| 2026-06-08 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | President and CEO | Sell | 6,153 | $211,356 |
| 2026-03-09 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | President and CEO | Buy | 42,452 | $0 |
| 2026-03-09 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | President and CEO | Sell | 20,025 | $634,192 |
| 2026-03-06 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | President and CEO | Buy | 50,223 | $0 |
| 2026-03-06 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | President and CEO | Sell | 23,393 | $759,337 |
| 2026-03-05 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | President and CEO | Buy | 67,231 | $0 |
| 2026-03-05 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | President and CEO | Sell | 30,903 | $1.0M |
| 2026-03-05 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | President and CEO | Buy | 891,315 | $0 |
| 2026-03-05 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | President and CEO | Sell | 412,032 | $13.3M |
| 2026-02-18 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | President and CEO | Buy | 161,656 | $0 |
| 2026-02-18 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | President and CEO | Sell | 161,656 | $5.5M |
| 2026-02-18 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | President and CEO | Buy | 620,110 | $0 |
| 2026-02-18 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | President and CEO | Sell | 286,122 | $9.8M |
来源：SEC Form 4 申报文件 · 截至 2026-06-08